ArticleCellular oncology (Dordrecht, Netherlands)2026
The MIF-CD74 axis drives colorectal cancer via glycolytic reprogramming and is targeted by a novel small-molecule inhibitor.
Jinwei Lou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.